Default: Marine Drugs

ISSN:

Journal Home

Journal Guideline

Marine Drugs Q1 Unclaimed

Multidisciplinary Digital Publishing Institute (MDPI) Switzerland
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Marine Drugs is a journal indexed in SJR in Drug Discovery with an H index of 159. It is an CC BY Journal with a Single blind Peer Review review system, and It has a price of 1840 €. The scope of the journal is focused on marine natural product. It has an SJR impact factor of 0,88 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 0,88.

Marine Drugs focuses its scope in these topics and keywords: alkaloids, current, benthic, sponge, marine, cf, deficienseffects, cytotoxic, cylindrospermopsin, cyanobacteriumzebrafishbased, ...

Type: Journal

Type of Copyright: CC BY

Languages: English

Open Access Policy: Open Access

Type of publications:

Publication frecuency: -

DOAJ Scopus WOS
Categories: Drug Discovery (Q1) Pharmaceutical Science (Q1) Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q1)
Price

1840 €

Inmediate OA

NPD

Embargoed OA

- €

Non OA

Metrics

Marine Drugs

0,88

SJR Impact factor

159

H Index

645

Total Docs (Last Year)

2161

Total Docs (3 years)

47974

Total Refs

12506

Total Cites (3 years)

2125

Citable Docs (3 years)

5.28

Cites/Doc (2 years)

74.38

Ref/Doc

Comments

No comments ... Be the first to comment!

Aims and Scope


alkaloids, current, benthic, sponge, marine, cf, deficienseffects, cytotoxic, cylindrospermopsin, cyanobacteriumzebrafishbased, cyanobacterium, diabetesplakofuranolactone, dinoflagellate, directionguanidine, discovery, egfinduced, erylus, erylusamides, extracts, crude, cosmetic, cosmeceutical, alexandrium, alga, allelopathyidentification, antibiotic, antiseizure, atypical, based, biosynthesis, cardiac, carotenoids, clustering, competition, compounds, marine natural product

FAQS